|
Indian Pediatr 2016;53: 1120 |
|
Clippings
Theme: Pediatric
Cardiology
|
R Krishna Kumar
Email:
[email protected]
|
|
Prevalence of congenital heart disease from Northern India (Ann
Pediatr Cardiol. 2016;9:205-9)
|
This large study (>20,000 newborns) provides important data about birth
prevalence of congenital heart disease (CHD) as a whole, and details of
individual CHDs. For the purpose of this study, significant CHD was
defined as all major CHDs (any CHD that was likely to require
intervention within the first year, including newborns with critical CHD
that require intervention within the first 4 weeks of life) or specific
forms of minor CHD (ASD >5 mm, PDA >2 mm with left ventricle volume
overload, restrictive VSD, and valvular aortic/pulmonary stenosis with
gradients <25 mmHg).
The birth prevalence of significant CHDs was 8.07 per
1000 live births, and approximately 20% of the defects identified at
birth were cyanotic CHDs. Among the acyanotic defects, ventricular
septal defect was the commonest; and among the cyanotic defects,
transposition of great arteries (TGA) was the commonest. It is important
to note that the birth prevalence of TGA was higher that tetralogy of
Fallot (TOF). Given the very high mortality of untreated TGA (~90% in
the first year), when compared to TOF (25% in the first year), it is not
surprising that TOF seems a lot commoner among older patients with CHD.
The study underscores the massive burden of CHD among
Indian children. From this prevalence data, it can be estimated that
approximately 100,000 babies are born each year with "major" and
"critical" CHD in India. The total number of operations in the limited
centers in India that perform infant and newborn heart surgery can
potentially take care of only about 10% of this disease burden. There is
clearly an urgent need to build national capacity to take care of the
remaining 90%.
|
|
Late causes of death after pediatric cardiac
surgery: A 60-year population-based study (J Am Coll
Cardiol. 2016;68:487-98)
|
In the past 4-5 decades, the care of children with congenital heart
disease (CHD) has been transformed by advances in pediatric
cardiovascular care, especially pediatric cardiac surgery. Corrective
surgery offers a prospect of survival with good quality of life for
children born with critical life-threatening CHD. The excellent health
systems and health records of Scandinavian nations provides a unique
opportunity to examine the long-term outcomes after congenital heart
surgery.
This study examines the results from a nationwide
pediatric cardiac surgery database and Finnish population registry of
10,964 patients undergoing 14,079 operations at <15 years of age in
hospitals in Finland from 1953 to 2009. A follow-up rate of 98% was
achieved. An early mortality (<30 days) of 5.6% perhaps reflects the
fact that the database includes the earliest era of congenital heart
surgery. The late mortality was 10.4%.
As expected, heart failure contributed to most
deaths. This decreased significantly after 1990, presumably reflecting
major advancements that have occurred in CHD surgery in the past three
decades. Sudden death after surgery for atrial septal defect,
ventricular septal defect, tetralogy of Fallot, and transposition of the
great arteries decreased to zero following operations from 1990 to 2009.
Deaths from neoplasms, respiratory, neurological, and infectious disease
were significantly more common among study patients than controls.
Pneumonia caused the majority of non–CHD-related deaths among the study
population.
The results of this study should be viewed as a benchmark for the
rest of the world, particularly low- and middle-income countries where
comprehensive pediatric cardiac care has only now begun to take shape.
Additionally, it is important to recognize that while patients operated
for CHD have vastly improved outcomes, they cannot, by any means,
considered as "cured".
|
|
Coronary artery complications in Kawasaki
disease and the importance of early intervention (JAMA
Pediatr. [published online October 17, 2016].
doi:10.1001/jamapediatrics.2016 .2055)
|
This meta-analysis of 16 comparative studies (Intravenous immunoglobulin
(IVIG) alone versus Steroids plus IVIG) that met predefined
criteria involving 2476 patients was carried out with the specific
purpose of determining the effect of corticosteroid therapy in
preventing coronary artery complications in patients with Kawasaki
disease (KD).
This systematic review and meta-analysis reveals that
corticosteroid therapy in addition to IVIG was associated with a
significantly lower rate of coronary artery complication compared with
intravenous immunoglobulin therapy alone, particularly among high-risk
patients (OR 0.240; 95% CI 0.123, 0.467). The benefits were maximal for
those with a relatively short duration of illness before corticosteroids
therapy and progressively diminished as the duration increased. The
duration of fever was significantly less in the corticosteroids group.
There was no increase in the risk of adverse events as a result of the
corticosteroid administration.
The impressive results in reduction of the most
serious complication of KD argues strongly in the favor of routine
administration of corticosteroids along with IVIG in all high-risk
patients with KD.
|
|
|
|